Chesapeake Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-711
Closed -$275K – 89
2026
Q2
$275K Buy
+711
New +$264K 0.14% 160

Other funds holding ELV

Chesapeake Capital's ELV Position: Q3 2026 in Review

Chesapeake Capital sold out of Elevance Health (ELV) in Q3 2026, closing a stake of 711 shares — an estimated $275K sold.

Chesapeake Capital first reported a position in ELV in Q2 2026 and held it in 1 quarter. The position peaked at $275K in Q2 2026. 1,621 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Chesapeake Capital reported no remaining Elevance Health position as of Q3 2026 after selling out during the quarter.
  • Chesapeake Capital sold 711 Elevance Health shares in Q3 2026, an estimated $275K.
  • Chesapeake Capital first reported a position in Elevance Health in Q2 2026 and held it in 1 quarter.
  • Chesapeake Capital's Elevance Health position peaked at $275K in Q2 2026.
  • 1,621 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Chesapeake Capital's 13F filing for Q3 2026, filed 9 Nov 2026.